Literature DB >> 10482644

Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes.

Y Chang1, C H Tung, Y T Huang, J Lu, J Y Chen, C H Tsai.   

Abstract

Two nasopharyngeal carcinoma (NPC) cell lines and one keratinocyte cell line could be infected with Epstein-Barr virus (EBV) by cocultivation with virus-producing cells but not by cell-free virus. Using porous culture inserts to manipulate the cell-to-cell contact, we demonstrated that contact between EBV donor B cells and EBV recipient epithelial cells was required for the infection. Cell-to-cell contact not only provided a CR2-independent route of infection but also enhanced CR2-mediated infection in a synergistic manner. Activity of two EBV promoters (Cp and Wp) and expression of EBNA2 were detected in the infected population. A small proportion of the infected cells spontaneously entered an EBV lytic state, which could be induced prominently by chemical treatment. This study provides information on how EBV may infect epithelial cells in vivo, such as at the onset of NPC development.

Entities:  

Mesh:

Year:  1999        PMID: 10482644      PMCID: PMC112911          DOI: 10.1128/JVI.73.10.8857-8866.1999

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism.

Authors:  J W Sixbey; Q Y Yao
Journal:  Science       Date:  1992-03-20       Impact factor: 47.728

2.  Epstein-Barr virus infection and replication in a human epithelial cell system.

Authors:  Q X Li; L S Young; G Niedobitek; C W Dawson; M Birkenbach; F Wang; A B Rickinson
Journal:  Nature       Date:  1992-03-26       Impact factor: 49.962

Review 3.  Neoplastic transformation of human epithelial cells in vitro.

Authors:  J S Rhim
Journal:  Anticancer Res       Date:  1989 Sep-Oct       Impact factor: 2.480

4.  Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells.

Authors:  M Rowe; H S Evans; L S Young; K Hennessy; E Kieff; A B Rickinson
Journal:  J Gen Virol       Date:  1987-06       Impact factor: 3.891

5.  Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.

Authors:  Y Chang; T S Sheen; J Lu; Y T Huang; J Y Chen; C S Yang; C H Tsai
Journal:  Lab Invest       Date:  1998-06       Impact factor: 5.662

6.  Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells.

Authors:  S Imai; J Nishikawa; K Takada
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  Epstein-Barr virus binding to CD21, the virus receptor, activates resting B cells via an intracellular pathway that is linked to B cell infection.

Authors:  M L Roberts; A T Luxembourg; N R Cooper
Journal:  J Gen Virol       Date:  1996-12       Impact factor: 3.891

8.  Productive infection of Epstein-Barr virus (EBV) in EBV-genome-positive epithelial cell lines (GT38 and GT39) derived from gastric tissues.

Authors:  N Takasaka; M Tajima; K Okinaga; Y Satoh; Y Hoshikawa; T Katsumoto; T Kurata; T Sairenji
Journal:  Virology       Date:  1998-08-01       Impact factor: 3.616

9.  Transcription of Epstein-Barr virus latent cycle genes in oral hairy leukoplakia.

Authors:  J Webster-Cyriaque; N Raab-Traub
Journal:  Virology       Date:  1998-08-15       Impact factor: 3.616

10.  Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency.

Authors:  L A Brooks; A L Lear; L S Young; A B Rickinson
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

View more
  53 in total

1.  Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands.

Authors:  A Janz; M Oezel; C Kurzeder; J Mautner; D Pich; M Kost; W Hammerschmidt; H J Delecluse
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Induction of Epstein-Barr virus latent membrane protein 1 by a lytic transactivator Rta.

Authors:  Yao Chang; Heng-Huan Lee; Shih-Shin Chang; Tsuey-Ying Hsu; Pei-Wen Wang; Yu-Sun Chang; Kenzo Takada; Ching-Hwa Tsai
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

3.  Epstein-Barr virus protein kinase BGLF4 targets the nucleus through interaction with nucleoporins.

Authors:  Chou-Wei Chang; Chung-Pei Lee; Yu-Hao Huang; Pei-Wen Yang; Jiin-Tarng Wang; Mei-Ru Chen
Journal:  J Virol       Date:  2012-05-23       Impact factor: 5.103

4.  Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells.

Authors:  Angela Kwok Fung Lo; Kwok Wai Lo; Sai Wah Tsao; Hing Lok Wong; Jan Wai Ying Hui; Ka Fai To; Diane S Hayward; Yiu Loon Chui; Yu Lung Lau; Kenzo Takada; Dolly P Huang
Journal:  Neoplasia       Date:  2006-03       Impact factor: 5.715

5.  Epstein-Barr virus BGLF4 kinase induces premature chromosome condensation through activation of condensin and topoisomerase II.

Authors:  Chung-Pei Lee; Jen-Yang Chen; Jiin-Tarng Wang; Keiji Kimura; Ai Takemoto; Chih-Chung Lu; Mei-Ru Chen
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

6.  Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells.

Authors:  Asuka Nanbo; Eri Kawanishi; Ryuji Yoshida; Hironori Yoshiyama
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

7.  Critical role of p53 in histone deacetylase inhibitor-induced Epstein-Barr virus Zta expression.

Authors:  Shih-Shin Chang; You-Chang Lo; Huey-Huey Chua; Hsin-Yi Chiu; Shu-Chun Tsai; Jen-Yang Chen; Kwok-Wai Lo; Ching-Hwa Tsai
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

8.  (-)-Epigallocatechin-3-gallate inhibition of Epstein-Barr virus spontaneous lytic infection involves downregulation of latent membrane protein 1.

Authors:  Sufang Liu; Hongde Li; Min Tang; Ya Cao
Journal:  Exp Ther Med       Date:  2017-11-13       Impact factor: 2.447

9.  Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle.

Authors:  Shih-Hsin Chiu; Meng-Chuan Wu; Chung-Chun Wu; Yu-Ching Chen; Su-Fang Lin; John T-A Hsu; Chung-Shi Yang; Ching-Hwa Tsai; Kenzo Takada; Mei-Ru Chen; Jen-Yang Chen
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

10.  Epstein-Barr virus BGLF4 kinase induces disassembly of the nuclear lamina to facilitate virion production.

Authors:  Chung-Pei Lee; Yu-Hao Huang; Su-Fang Lin; Yao Chang; Yu-Hsin Chang; Kenzo Takada; Mei-Ru Chen
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.